Related Experiment Video
Updated: Aug 23, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Evolving use of buprenorphine in the treatment of addiction
1The 14th Street Clinic, Oakland, California 94606, USA. jmrtn@earthlink.net
Abstract:
Two formulations of buprenorphine were approved in the United States for treatment of opioid dependence in 2002. This newly available treatment offers a safe and effective alternative to addicted individuals who are not currently in treatment. This article focuses on the steps that physicians and patients may take, as of this writing, if they should wish to participate in this new treatment. The content is clinically oriented and intelligible to an audience that is not medically trained. In the article, buprenorphine is placed in context of the standard opioid pharmacotherapy of methadone maintenance, and the expansion of opioid pharmacotherapy into the office setting is described.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Dependence
Analgesia and Pain Management
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Opioid Analgesics: Morphine and Other Natural Cogeners

